Comorbid conditions in schizophrenia

Current Opinion in Psychiatry

Volumn 14, Issue 1, 2001, Pages 17-23

  Fenton, Wayne S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; HUMAN; HYPERGLYCEMIA; OBESITY; OBSESSION; PANIC; REVIEW; SCHIZOPHRENIA; SUBSTANCE ABUSE; WEIGHT GAIN;

EID: 0034991433     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-200101000-00004     Document Type: Review

References (50)

1. At issue: Hierarchical diagnosis in chronic schizophrenia: A clinical study of co-occurring syndromes
2. Management of schizophrenia with comorbid conditions
3. The structure of psychosis: Latent class analysis of probands from Roscommon Family Study
4. Mood disorders in schizophrenia: Epidemiology and comorbidity
5. Prevalence and background factors of depression in first admitted schizophrenia patients
6. Depressive symptoms in schizophrenia
7. Reliability and validity of the DSM IV diagnostic category of schizoaffective disorder: Preliminary data
8. Mortality and causes of death in Stockholm County, Sweden
9. Suicidal behavior in schizophrenia: Characteristics of individuals who had and had not attempted suicide
10. Suicidal behavior in patients with schizophrenia and other psychotic disorders
11. Depression, suicide, and suicide prevention in schizophrenia
12. Depression in schizophrenia: Perspectives in the era of 'atypical' antipsychotic agents
13. Treatment of schizoaffective disorder and schizophrenia with mood symptoms
14. Obsessive-compulsive disorder in patients with first-episode schizophrenia
15. Obsessive-compulsive disorder in schizophrenia
16. Management of schizophrenia with obsessive-compulsive disorder
17. Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: A pilot study
18. Obsessive and compulsive symptoms in schizophrenia
19. Obsessive-compulsive symptoms with risperidone
20. Olanzapine-induced obsessive-compulsive disorder
21. Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms
22. Lifetime prevalence of mood and anxiety disorders in twin pairs discordant for schizophrenia
23. Panic disorder in schizophrenia
24. Relationship of panic attacks to paranoia
25. Treatment of comorbid panic disorder and schizophrenia: Evidence for a panic psychosis
26. Weight gain from novel antipsychotic drugs: Need for action
27. Weight gain: Side effect of atypical antipsychotics?
28. Obesity: What mental health professionals need to know
29. Antipsychotic-induced weight gain: A comprehensive research synthesis
30. Ziprasidone 80mg/day and 160mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A six week placebo-controlled trial
31. Differential influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses
32. Clozapine-associated elevation in serum triglycerides
33. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five year naturalistic study
34. Olanzapine increases weight and serum triglyceride levels
35. Olanzapine-induced elevation of plasma triglyceride levels
36. Body mass index increase of 58% associated with olanzapine
37. Olanzapine-induced ketoacidosis with diabetes mellitus
38. H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients
39. Clozapine weight gain, plus topiramate weight loss
40. Schizophrenia, substance misuse and smoking
41. Substance use disorder in hospitalized severely mentally ill psychiatric patients: Prevalence, correlates and subgroups
42. The prevalence of comorbid substance misuse and its influence on suicidal ideation among inpatients with schizophrenia
43. Double jeopardy: Schizophrenia and substance use
44. Service use and costs of people with dual diagnosis in South London
45. Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia
46. Substance use disorders in schizophrenia: Review, integration, and a proposed model
47. Psychosocial approaches to dual diagnosis
48. Management of substance abuse in schizophrenia
49. Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence
50. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia